The Cancer Center at Hackensack University Medical Center is a clinical research site located in Hackensack, New Jersey, United States 07601.
Crixeo Health Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.
The Cancer Center at Hackensack University Medical Center has participated in 20 clinical trials with 1 currently active.
Therapeutic areas: Peripheral T-cell Lymphoma, Renal Cell Carcinoma, Metastases.
Sponsors: Acrotech Biopharma Inc., Genentech, Inc., Cyclacel Pharmaceuticals, Inc..
Trust Score: 82/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
The Cancer Center at Hackensack University Medical Center has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The Cancer Center at Hackensack University Medical Center has 20 clinical trials on record, with 1 currently active. Their work covers Peripheral T-cell Lymphoma, Renal Cell Carcinoma, Metastases.
Yes — The Cancer Center at Hackensack University Medical Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.